Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury

Acute kidney disease (AKI) leads to increased risk of progression to chronic kidney disease (CKD). Antithrombin III (ATIII) is a potent anticoagulant with anti‐inflammatory properties, and we previously reported that insufficiencies of ATIII exacerbated renal ischaemia‐reperfusion injury (IRI) in ra...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Mol Med
Päätekijät: Yin, Jianyong, Wang, Feng, Kong, Yiwei, Wu, Rui, Zhang, Guangyuan, Wang, Niansong, Wang, Ling, Lu, Zeyuan, Liang, Mingyu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706518/
https://ncbi.nlm.nih.gov/pubmed/28767184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13261
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia